β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats
Keyword(s):
Ang Ii
◽
We have synthesized a highly selective compound that is able to target a protein-binding site [called angiotensin (Ang) II type 2 receptor, AT2R] in the cardiovascular system. This research tool will enhance our ability to stimulate AT2R to produce protective effects against cardiovascular disease.
2005 ◽
Vol 25
(7)
◽
pp. 878-886
◽
2005 ◽
Vol 23
(5)
◽
pp. 1037-1045
◽
2017 ◽
Vol 34
(1)
◽
pp. 43-54
◽